| Market Cap | 6.7B |
| Market Cap (USD) | $927.4M |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | 0.21 |
| Dividend Yield | - |
| D/E Ratio | 0.24 |
| Current Ratio | 3.04 |
| Market Segment | ChiNext |
| Currency | CNY |
Business Overview
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | C27医药制造业 |
| Market Segment | ChiNext |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 迈克生物 |
| Ticker | 300463 |
| Exchange | SZSE |
| Sector | 证监会行业分类 |
| Industry | C27医药制造业 |
| Market Segment | ChiNext |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 6.7B |
| Market Cap (USD) | $927.4M |
| Revenue | 2.5B |
| Net Income | 119.0M |
| P/E Ratio | - |
| EPS | 0.21 |
| Net Margin | 4.7% |
| ROE | 1.9% |
| Dividend Yield | - |
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.